Showing results (281-290 of 322) with videos related to
Sort By:
Pageof 33
Neurology|May 10, 2000
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study GroupS L Hauser, J R Oksenberg, R Lincoln, et al.Veterinary Journal (London, England : 1997)|June 28, 2015
AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscleM A de Laat, M A Robinson, K J Gruntmeir, et al.Genes and Immunity|June 10, 2011
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patientsJ P McElroy, N Isobe, P A Gourraud, et al.Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.Drugs|January 1, 1976
Clinical and haemodynamic effects of minoxidil in refractory hypertensionR Zacest, D B Frewin, M A Robinson, et al.Genes and Immunity|June 27, 2008
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosisL F Barcellos, P P Ramsay, S J Caillier, et al.Journal of Veterinary Pharmacology and Therapeutics|May 29, 2012
Pharmacokinetics of dexamethasone following intra-articular, intravenous, intramuscular, and oral administration in horses and its effects on endogenous hydrocortisoneL R Soma, C E Uboh, Y Liu, et al.Neurogenetics|November 21, 2001
Linkage and association analysis of chromosome 19q13 in multiple sclerosisM A Pericak-Vance, J B Rimmler, E R Martin, et al.Neurology|May 20, 2009
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measuresE M Mowry, A Beheshtian, E Waubant, et al.Nature Genetics|August 31, 2001
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patientsL F Barcellos, S Caillier, L Dragone, et al.Pageof 33